search
Back to results

Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients

Primary Purpose

Myocardial Reperfusion Injury, Hypoxia, Hyperoxia

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hypoxic-hyperoxic preconditioning
Placebo
Sponsored by
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myocardial Reperfusion Injury focused on measuring myocardial protection, preconditioning, hypoxia, hyperoxia, ischemia-reperfusion injury, cardiopulmonary bypass, oxygen transport

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • the need for coronary artery bypass grafting (CABG)

Exclusion Criteria:

  • age over 75 years
  • emergency surgery
  • diabetes mellitus
  • exacerbation of a chronic disease 1 week before surgery
  • any oncological disease at the time of the examination

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    Hypoxic-hyperoxic preconditioning (HHP)

    Control

    Arm Description

    HHP was carried out as follows: breathing with a hypoxic gas mixture for 10 min with the development of hypoxemia, then breathing with a hyperoxic gas mixture for 30 minutes, and at the last stage, a period of breathing with atmospheric air until the cardio-pulmonary bypass is connected. The anaerobic threshold was determined 72 hours before surgery to establish a safe oxygen concentration in the respiratory gas mixture during the hypoxic phase of preconditioning.

    The anaerobic threshold was determined, however, patients in the control group were not preconditioned. Mechanical ventilation was carried out with individual settings maintaining the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively), until the cardio-pulmonary bypass was connected.

    Outcomes

    Primary Outcome Measures

    Number of Participants with complications
    Any type of complications in postoperative period
    Mechanical ventilation
    Mechanical ventilation time
    Rate of spontaneous sinus rhythm recovery
    Spontaneous sinus rhythm recovery after surgery

    Secondary Outcome Measures

    Catecholamine support
    Catecholamine support time
    Troponin T
    Troponin T concentration
    Endothelin-1
    Endothelin-1 concentrations
    Endothelin-1 dynamics 1
    Endothelin-1 concentrations
    Endothelin-1 dynamics 2
    Endothelin-1 concentrations
    NOx total
    NOx total concentrations
    NOx total dynamics 1
    NOx total concentrations
    NOx total dynamics 2
    NOx total concentrations
    Asymmetric dimethylarginine (ADMA)
    ADMA concentrations
    ADMA dymanics 1
    ADMA concentrations
    ADMA dymanics 2
    ADMA concentrations

    Full Information

    First Posted
    April 26, 2022
    Last Updated
    May 6, 2022
    Sponsor
    Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
    Collaborators
    Tomsk National Research Medical Center of the Russian Academy of Sciences, Siberian State Medical University, I.M. Sechenov First Moscow State Medical University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05354648
    Brief Title
    Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients
    Official Title
    Effects of Hypoxic-hyperoxic Preconditioning on Myocardial Protection Against Ischemia-reperfusion Injury in Cardio-surgical Patients
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2022
    Overall Recruitment Status
    Completed
    Study Start Date
    June 1, 2015 (Actual)
    Primary Completion Date
    January 15, 2016 (Actual)
    Study Completion Date
    February 22, 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
    Collaborators
    Tomsk National Research Medical Center of the Russian Academy of Sciences, Siberian State Medical University, I.M. Sechenov First Moscow State Medical University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Coronary artery bypass grafting (CABG) with cardiopulmonary bypass is a common surgical therapy for patients suffering from coronary artery diseases. The heart is subjected to a long period of ischemia due to the occlusion of the aorta. The heavy burden of myocardial ischemia-reperfusion injury (IRI) thus induces cardiomyocyte death, which can paradoxically reduce the beneficial effect of CABG. Preconditioning by moderate hypoxia or hyperoxia serves as an effective drug-free method to increase the organism's resistance to negative effects, including IRI.
    Detailed Description
    It has been firmly established that the diminished oxygen delivery to the tissues in response to hypoxia is countered by a combination of the increased regional blood flow and the enhanced functional capillary density in the microcirculation. In experimental studies, exposure to hyperoxia for a limited time before ischemia induces a low-grade systemic oxidative stress evokes a preconditioning-like effect on the myocardium and reduces the infarction area by 20%, and the number of arrhythmias after ischemia-reperfusion. One hundred twenty patients were randomly assigned into two equal groups: hypoxic-hyperoxic preconditioning before the surgery (HHP group) and the control group (without preconditioning). Safety control of the preconditioning procedure included ECG monitoring, invasive blood pressure, cardiac output, pulse oximetry, capnography, cerebral oximetry, measurement of anaerobic threshold; acid-base status and metabolic state of arterial and venous blood were assessed once every 10 min during the preconditioning procedure; oxygen balance parameters were calculated. Seventy-two hours before the surgery, an anaerobic threshold was determined to establish a safe oxygen concentration in the respiratory gas mixture during the hypoxic preconditioning phase from 10 to 14%, followed by 75-80% oxygen concentration during the hyperoxic phase. The hypoxic-hyperoxic preconditioning with individual parameters selection based on the anaerobic threshold in patients with coronary artery diseases before the main stage of cardiac surgery with a cardiopulmonary bypass should reduce the duration of mechanical ventilation, catecholamine support, and frequency of perioperative complications.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Myocardial Reperfusion Injury, Hypoxia, Hyperoxia, Coronary Artery Disease
    Keywords
    myocardial protection, preconditioning, hypoxia, hyperoxia, ischemia-reperfusion injury, cardiopulmonary bypass, oxygen transport

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    120 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Hypoxic-hyperoxic preconditioning (HHP)
    Arm Type
    Active Comparator
    Arm Description
    HHP was carried out as follows: breathing with a hypoxic gas mixture for 10 min with the development of hypoxemia, then breathing with a hyperoxic gas mixture for 30 minutes, and at the last stage, a period of breathing with atmospheric air until the cardio-pulmonary bypass is connected. The anaerobic threshold was determined 72 hours before surgery to establish a safe oxygen concentration in the respiratory gas mixture during the hypoxic phase of preconditioning.
    Arm Title
    Control
    Arm Type
    Placebo Comparator
    Arm Description
    The anaerobic threshold was determined, however, patients in the control group were not preconditioned. Mechanical ventilation was carried out with individual settings maintaining the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively), until the cardio-pulmonary bypass was connected.
    Intervention Type
    Procedure
    Intervention Name(s)
    Hypoxic-hyperoxic preconditioning
    Other Intervention Name(s)
    HHP
    Intervention Description
    Patients were intubated and mechanically ventilated with the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively) under the inhalation anesthesia. HHP was carried out as follows: breathing with a hypoxic gas mixture for 10 min with the development of hypoxemia, then breathing with a hyperoxic gas mixture for 30 minutes, then a period of breathing with atmospheric air (normoxia and normocapnia) until the cardio-pulmonary bypass is connected.
    Intervention Type
    Procedure
    Intervention Name(s)
    Placebo
    Intervention Description
    Patients were intubated and mechanically ventilated with the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively) under the inhalation anesthesia until the cardio-pulmonary bypass is connected.
    Primary Outcome Measure Information:
    Title
    Number of Participants with complications
    Description
    Any type of complications in postoperative period
    Time Frame
    60 days
    Title
    Mechanical ventilation
    Description
    Mechanical ventilation time
    Time Frame
    60 days
    Title
    Rate of spontaneous sinus rhythm recovery
    Description
    Spontaneous sinus rhythm recovery after surgery
    Time Frame
    14 days
    Secondary Outcome Measure Information:
    Title
    Catecholamine support
    Description
    Catecholamine support time
    Time Frame
    60 days
    Title
    Troponin T
    Description
    Troponin T concentration
    Time Frame
    12 hours
    Title
    Endothelin-1
    Description
    Endothelin-1 concentrations
    Time Frame
    1 day before surgery
    Title
    Endothelin-1 dynamics 1
    Description
    Endothelin-1 concentrations
    Time Frame
    at the end of surgery
    Title
    Endothelin-1 dynamics 2
    Description
    Endothelin-1 concentrations
    Time Frame
    24 hours after surgery
    Title
    NOx total
    Description
    NOx total concentrations
    Time Frame
    1 day before surgery
    Title
    NOx total dynamics 1
    Description
    NOx total concentrations
    Time Frame
    at the end of surgery
    Title
    NOx total dynamics 2
    Description
    NOx total concentrations
    Time Frame
    24 hours after surgery
    Title
    Asymmetric dimethylarginine (ADMA)
    Description
    ADMA concentrations
    Time Frame
    1 day before surgery
    Title
    ADMA dymanics 1
    Description
    ADMA concentrations
    Time Frame
    at the end of surgery
    Title
    ADMA dymanics 2
    Description
    ADMA concentrations
    Time Frame
    24 hours after surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: the need for coronary artery bypass grafting (CABG) Exclusion Criteria: age over 75 years emergency surgery diabetes mellitus exacerbation of a chronic disease 1 week before surgery any oncological disease at the time of the examination
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Irina A Mandel, PhD
    Organizational Affiliation
    Federal Research Clinical Center FMBA Russia
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    32727110
    Citation
    Mandel IA, Podoksenov YK, Suhodolo IV, An DA, Mikheev SL, Podoksenov AY, Svirko YS, Gusakova AM, Shipulin VM, Yavorovskiy AG. Influence of Hypoxic and Hyperoxic Preconditioning on Endothelial Function in a Model of Myocardial Ischemia-Reperfusion Injury with Cardiopulmonary Bypass (Experimental Study). Int J Mol Sci. 2020 Jul 27;21(15):5336. doi: 10.3390/ijms21155336.
    Results Reference
    background

    Learn more about this trial

    Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients

    We'll reach out to this number within 24 hrs